Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Calpain 9 Antikörper (AA 591-690)

CAPN9 Reaktivität: Human WB, ELISA, IHC (p) Wirt: Maus Monoclonal 3A6 unconjugated
Produktnummer ABIN564689
  • Target Alle Calpain 9 (CAPN9) Antikörper anzeigen
    Calpain 9 (CAPN9)
    Bindungsspezifität
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 591-690
    Reaktivität
    • 24
    • 4
    • 3
    • 1
    • 1
    Human
    Wirt
    • 18
    • 6
    Maus
    Klonalität
    • 19
    • 5
    Monoklonal
    Konjugat
    • 17
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Calpain 9 Antikörper ist unkonjugiert
    Applikation
    • 15
    • 7
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Verwendungszweck
    Mouse monoclonal antibody raised against a partial recombinant CAPN9.
    Sequenz
    DKLKQWINLF LRFDADKSGT MSTYELRTAL KAAGFQLSSH LLQLIVLRYA DEELQLDFDD FLNCLVRLEN ASRVFQALST KNKEFIHLNI NEFIHLTMNI
    Kreuzreaktivität
    Human
    Produktmerkmale
    Antibody Reactive Against Recombinant Protein.
    Immunogen
    CAPN9 (NP_006606, 591 a.a. ~ 690 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
    Klon
    3A6
    Isotyp
    IgG2a
    Top Product
    Discover our top product CAPN9 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    In 1x PBS, pH 7.4
    Handhabung
    Aliquot to avoid repeated freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Davis, Martin, Patel, Green, Rakha, Ellis, Storr: "Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer." in: BMC cancer, Vol. 14, pp. 995, (2015) (PubMed).

    Storr, Pu, Davis, Lobo, Reece-Smith, Parsons, Madhusudan, Martin: "Expression of the calpain system is associated with poor clinical outcome in gastro-oesophageal adenocarcinomas." in: Journal of gastroenterology, Vol. 48, Issue 11, pp. 1213-21, (2013) (PubMed).

    Chen, Nguyen, Shively: "Role of calpain-9 and PKC-delta in the apoptotic mechanism of lumen formation in CEACAM1 transfected breast epithelial cells." in: Experimental cell research, Vol. 316, Issue 4, pp. 638-48, (2010) (PubMed).

    Hata, Abe, Suzuki, Kitamura, Toyama-Sorimachi, Abe, Sakimura, Sorimachi: "Calpain 8/nCL-2 and calpain 9/nCL-4 constitute an active protease complex, G-calpain, involved in gastric mucosal defense." in: PLoS genetics, Vol. 6, Issue 7, pp. e1001040, (2010) (PubMed).

  • Target
    Calpain 9 (CAPN9)
    Andere Bezeichnung
    CAPN9 (CAPN9 Produkte)
    Synonyme
    MGC83034 antikoerper, cb545 antikoerper, zgc:92451 antikoerper, wu:fb77d06 antikoerper, CAPN9 antikoerper, GC36 antikoerper, nCL-4 antikoerper, 2200003B16Rik antikoerper, nCL4 antikoerper, Ncl-4 antikoerper, calpain 9 antikoerper, calpain 9 S homeolog antikoerper, CAPN9 antikoerper, capn9.S antikoerper, capn9 antikoerper, Capn9 antikoerper
    Hintergrund
    Full Gene Name: calpain 9
    Synonyms: GC36,nCL-4
    Gen-ID
    10753
    NCBI Accession
    NM_006615
Sie sind hier:
Kundenservice